The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Panitumumab as a single agent in 269 metastatic colorectal cancer patients in the real practice: A post EMA approval study.
Francoise Grude
No relevant relationships to disclose
Jean François Ramée
No relevant relationships to disclose
Laurent Guivarch
No relevant relationships to disclose
Sophie Rochard
No relevant relationships to disclose
Olivier Dupuis
No relevant relationships to disclose
Chrystelle Grollier
No relevant relationships to disclose
Veronique Guerin-Meyer
No relevant relationships to disclose
Pierre Leynia
No relevant relationships to disclose
Marc Porneuf
No relevant relationships to disclose
Elodie Peguet
No relevant relationships to disclose
Eveline Boucher
No relevant relationships to disclose
Claude Bertrand
No relevant relationships to disclose
Philippe Deguiral
No relevant relationships to disclose
Laurent Derenne
No relevant relationships to disclose
Nacredine Achour
No relevant relationships to disclose
Bernadette Person
No relevant relationships to disclose
Marie-Annick Lebot
No relevant relationships to disclose
Christian Riche
No relevant relationships to disclose
Jean Philippe Metges
No relevant relationships to disclose
Jean Yves Douillard
No relevant relationships to disclose